🕵️ Integra Lifesciences Holdings Corp ($IART)
SEC insider & ownership activity, last 12 months · CIK 917520 · every row links its SEC filing
Over the last 12 months insiders bought $102K with no open-market selling against it. Jeffrey A. Graves bought $102K in discretionary trades (Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $102K (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jeffrey A. Graves | 1 | $102K | 0 | – | Nov 5, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 13.2% | 13G | Jul 17, 2025 | filing ↗ | |
| Rubric Capital Management LP | 9.5% | 13G | Jul 9, 2025 | filing ↗ | |
| David Rosen | 9.5% | 13G | Jul 9, 2025 | filing ↗ | |
| Paradigm Capital Management INC/NY | 5.2% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 7, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 10, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 11, 2025 | filing ↗ |
| Earnings (2.02) | Oct 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 30, 2025 | filing ↗ |
| Earnings (2.02) | Jul 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing ↗ |